Cash Dividend On The Way From Chesapeake Energy (CHK)

Looking at the universe of stocks we cover at Dividend Channel, on 1/13/14, Chesapeake Energy Corp. (CHK) will trade ex-dividend, for its quarterly dividend of $0.0875, payable on 1/31/14. As a percentage of CHK's recent stock price of $25.95, this dividend works out to approximately 0.34%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CHK, showing historical dividends prior to the most recent $0.0875 declared by Chesapeake Energy Corp.:

CHK+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CHK is likely to continue, and whether the current estimated yield of 1.35% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of CHK shares, versus its 200 day moving average:

Chesapeake Energy Corp. 200 Day Moving Average Chart

Looking at the chart above, CHK's low point in its 52 week range is $16.37 per share, with $29.06 as the 52 week high point — that compares with a last trade of $25.93.

According to the ETF Finder at ETF Channel, CHK makes up 4.78% of the Dynamic Energy Exploration & Production Portfolio ETF ( PXE) which is trading higher by about 0.2% on the day Thursday.

In Thursday trading, Chesapeake Energy Corp. shares are currently up about 0.4% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says